缺血性 priapism 的手术管理:有哪些新的选择?
Rohit Badia1, Sidney Roberts1, Alexandria Hertz1
1Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
概括
缺血性 priapism 需要紧急治疗,以防止永久性损伤和勃起功能障碍. 新的外科手术技术显示出解决priapism的希望,并可能恢复性功能.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
背景情况:
- 缺血性priapism是一个关键的泌尿器科紧急情况.
- 延迟治疗可能导致体纤维化和严重的勃起功能障碍.
研究的目的:
- 审查关于缺血性青症管理的当前文献.
- 专注于评估最新的外科手术技术.
主要方法:
- 在2024年6月进行的PubMed数据库搜索.
- 关键词:"嗜食症"",手术管理".
- 独立的文章评论由两位作者撰写.
主要成果:
- 床边操作 (吸收,灌,同情药物) 对于急性病例 (<24小时) 有效.
- 长时间的priapism可能需要积极的干预措施.
- 新的道挖掘技术 (阴囊部减压,身体蛇机动) 显示出有希望的结果.
结论:
- 及时干预对于缺血性priapism至关重要.
- 新兴的外科手术技术提供了前症解决和性功能恢复的潜力.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
153
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
153
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
129
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
129